Oncology & Cancer

Hippocampal avoidance during WBRT reduces risks in oncology trial

Results from the NRG Oncology clinical study NRG-CC001 concluded that lowering radiotherapy dose to hippocampal stem cells improves cognitive and patient-reported outcomes for patients with brain metastases. These findings ...

Oncology & Cancer

Targeted hope for metastatic cancer

A cancer diagnosis is tough enough to hear, but a diagnosis that cancer has spread through the body has often been considered a death sentence.

Oncology & Cancer

Big data analysis predicts risk of radiotherapy side effects

Analysing big data to predict men's risk of side effects could help personalise radiotherapy treatment for prostate cancer, according to new research presented at the National Cancer Research Institute's (NCRI) Cancer Conference ...

page 1 from 3